IZOZ.F Stock Overview
A research and development company, develops diagnostic products for detecting breast cancers. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Izotropic Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.039 |
| 52 Week High | CA$0.18 |
| 52 Week Low | CA$0.031 |
| Beta | 1.79 |
| 11 Month Change | -23.53% |
| 3 Month Change | -42.98% |
| 1 Year Change | -61.00% |
| 33 Year Change | -95.12% |
| 5 Year Change | -77.06% |
| Change since IPO | -85.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| IZOZ.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 10.8% | -0.03% | 0.4% |
| 1Y | -61.0% | 21.3% | 32.3% |
Return vs Industry: IZOZ.F underperformed the US Medical Equipment industry which returned 20.5% over the past year.
Return vs Market: IZOZ.F underperformed the US Market which returned 32.2% over the past year.
Price Volatility
| IZOZ.F volatility | |
|---|---|
| IZOZ.F Average Weekly Movement | 38.8% |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: IZOZ.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: IZOZ.F's weekly volatility has increased from 33% to 39% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | Bob Thast | izocorp.com |
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.
Izotropic Corporation Fundamentals Summary
| IZOZ.F fundamental statistics | |
|---|---|
| Market cap | US$2.02m |
| Earnings (TTM) | -US$1.67m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.2x
P/E RatioIs IZOZ.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IZOZ.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$2.35m |
| Earnings | -CA$2.35m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.041 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -46.7% |
How did IZOZ.F perform over the long term?
See historical performance and comparison